Related Experiment Video
Updated: Sep 19, 2025

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
Published on: April 11, 2016
Upregulating vascular endothelial KCa2.3 channels alleviates pulmonary hypertension in mice
Meng-Zhuan Han1, Yan Wang1, Ke-Xin Sun2
1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Abstract:
Endothelial dysfunction of pulmonary arteries is important in the initiation of pulmonary hypertension (PH). Pulmonary vascular tone is regulated by endothelium-dependent hyperpolarization (EDH) that induces vasodilation. Although KCa2.3 channels are involved as a key initiator of EDH response, therapeutic potential of endothelial KCa2.3 channels in PH remains unclear. Bioinformatic and biochemical analyses were used to explore KCa2.3 expression in patients with PH. Two mouse PH models were created by injection of Sugen 5416 plus hypoxia or injection with monocrotaline. Endothelial-specific KCa2.3 adeno-associated virus (AAV-Kcnn3) was constructed, and the efficacy in both PH models was tested using immunohistochemistry, myograph system, and echocardiography. Expression of KCa2.3 was decreased in pulmonary arterial endothelial cells or lung tissues from patients with PH and both experimental PH models. AAV-Kcnn3 treatment increased KCa2.3 expression in pulmonary endothelium and ameliorated KCa2.3-medieated vasodilation of small pulmonary arteries and pulmonary vascular endothelial dysfunction in both PH models. The key PH phenotypes, including elevated right ventricular pressure, Fulton index, pulmonary artery wall thickness, and the free wall thickness of the right ventricle, were remarkably alleviated by AAV-Kcnn3 treatment in both PH models. In conclusion, augmented expression of endothelium-specific KCa2.3 channels markedly inhibits the development of PH by improving endothelium-dependent relaxation. SIGNIFICANCE STATEMENT: This study demonstrated downregulated expression of KCa2.3 channels in lung tissues, specifically in pulmonary artery endothelial cells from patients or mice with pulmonary hypertension. Upregulation of endothelial KCa2.3 might serve as a therapeutic strategy in the early-stage pulmonary hypertension.
More Related Videos
10:20Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Regulation of Angiogenesis and Blood Supply